MCRN Clinical Studies Groups (CSGs) Laura Pilkington Clinical Studies Group Administrator The NIHR Medicines for Children ...
What are MCRN CSGs? <ul><li>MCRN CSGs are panels of stakeholders relevant to medicines for children who have the general r...
12 MCRN CSGs <ul><li>Allergy, Infection & Immunity Dr Mike Sharland </li></ul><ul><li>Anaesthesia, Pain, Intensive Care & ...
MCRN CSG Membership
Role of MCRN CSGs Reactive Role Proactive Role To provide advice to investigators for the development of research proposal...
Reactive Role “Provision of advice to investigators and Commercial Companies” **October 2008**
Proactive Role (1) “Identifying gaps in research and working to address them” <ul><li>IDENTIFICATION OF RESEARCH PRIORITIE...
Proactive Role (2) <ul><li>DEVELOPMENT OF RESEARCH PROPOSALS </li></ul><ul><li>Respiratory and Cystic Fibrosis CSG (two st...
Proactive Role (3) <ul><li>OTHER KEY ACTIVITIES/ACHIEVEMENTS </li></ul><ul><li>Pharmacy and Pharmacology CSG – Pharmaceuti...
The NIHR Medicines for Children Research Network is part of the National Institute for Health Research Clinical Research N...
Upcoming SlideShare
Loading in...5
×

Laura Pilkington (CSG Administrator) - MCRN Clinical Studies ...

469

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
469
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Laura Pilkington (CSG Administrator) - MCRN Clinical Studies ...

  1. 1. MCRN Clinical Studies Groups (CSGs) Laura Pilkington Clinical Studies Group Administrator The NIHR Medicines for Children Research Network is part of the National Institute for Health Research Clinical Research Network, and forms part of the UK Clinical Research Network. The Networks support and deliver high quality clinical research studies.
  2. 2. What are MCRN CSGs? <ul><li>MCRN CSGs are panels of stakeholders relevant to medicines for children who have the general remit to: </li></ul><ul><li>Provide expert advice to investigators, the pharmaceutical industry and to the MCRN Study Adoption Committee (SAC) </li></ul><ul><li>- Identify gaps within current research and develop studies to successfully address these gaps </li></ul>
  3. 3. 12 MCRN CSGs <ul><li>Allergy, Infection & Immunity Dr Mike Sharland </li></ul><ul><li>Anaesthesia, Pain, Intensive Care & Cardiology Dr Robert Tasker </li></ul><ul><li>Diabetes, Endocrinology & Metabolic Medicine Prof David Dunger </li></ul><ul><li>Gastroenterology, Hepatology & Nutrition Dr Stephen Murphy </li></ul><ul><li>General Paediatrics Dr Colin Powell </li></ul><ul><li>Methodology Prof Peter Brocklehurst </li></ul><ul><li>Neonatal Dr Mark Turner </li></ul><ul><li>MCRN/BAPN Nephrology CSG Prof Moin Saleem </li></ul><ul><li>Neurosciences Dr Timothy Martland </li></ul><ul><li>Pharmacy & Pharmacology Prof Ian Wong </li></ul><ul><li>Respiratory & Cystic Fibrosis Dr Paul Seddon </li></ul><ul><li>MCRN/arc Paediatric Rheumatology Dr Michael Beresford </li></ul>
  4. 4. MCRN CSG Membership
  5. 5. Role of MCRN CSGs Reactive Role Proactive Role To provide advice to investigators for the development of research proposals and funding applications To identify gaps in current research within specialty areas and determine research priorities To provide advice to commercial companies through the MCRN Industry Liaison Team To develop clinical trials or other well designed studies to address research gaps To advise the MCRN Study Adoption Committee regarding the quality of studies submitted to run through the network To participate in strategic decisions of the MCRN through representation on the MCRN Board
  6. 6. Reactive Role “Provision of advice to investigators and Commercial Companies” **October 2008**
  7. 7. Proactive Role (1) “Identifying gaps in research and working to address them” <ul><li>IDENTIFICATION OF RESEARCH PRIORITIES </li></ul><ul><li>Development of research priorities – April 2007 </li></ul><ul><li>Neonatal CSG and ENN: survey of medicines use in Neonatal units – December 2007 </li></ul><ul><li>ERANET Project – January 2008 </li></ul>
  8. 8. Proactive Role (2) <ul><li>DEVELOPMENT OF RESEARCH PROPOSALS </li></ul><ul><li>Respiratory and Cystic Fibrosis CSG (two studies funded) </li></ul><ul><li>Cross-CSG Obesity Planning Group – (application submitted to HTA; awaiting outcome) </li></ul><ul><li>Gastroenterology, Hepatology and Nutrition CSG IBD and Liver Brainstorming with BSPGHAN (application in progress) </li></ul><ul><li>Formulations Subgroup application to NIHR Programme Grants for Applied Research (application in progress) </li></ul>
  9. 9. Proactive Role (3) <ul><li>OTHER KEY ACTIVITIES/ACHIEVEMENTS </li></ul><ul><li>Pharmacy and Pharmacology CSG – Pharmaceutical Translational Research Conference (April 2 nd to April 3 rd 2009) </li></ul><ul><li>External funding obtained from medical research charities to establish new CSGs: MCRN/arc Paediatric Rheumatology CSG; MCRN/BAPN Nephrology CSG (funding from KKR) </li></ul>
  10. 10. The NIHR Medicines for Children Research Network is part of the National Institute for Health Research Clinical Research Network, and forms part of the UK Clinical Research Network. The Networks support and deliver high quality clinical research studies. Laura Pilkington Clinical Studies Groups Administrator   UK Medicines for Children Research Network University of Liverpool Institute of Child Health Alder Hey Children's Hospital Liverpool, L12 2AP Tel:  0151 282 4720 Fax: 0151 282 4719 [email_address]
  1. A particular slide catching your eye?

    Clipping is a handy way to collect important slides you want to go back to later.

×